摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methoxy-2-(triphenyl-lambda5-phosphanylidene)acetaldehyde | 2943-27-3

中文名称
——
中文别名
——
英文名称
2-Methoxy-2-(triphenyl-lambda5-phosphanylidene)acetaldehyde
英文别名
2-methoxy-2-(triphenyl-λ5-phosphanylidene)acetaldehyde
2-Methoxy-2-(triphenyl-lambda5-phosphanylidene)acetaldehyde化学式
CAS
2943-27-3
化学式
C21H19O2P
mdl
——
分子量
334.354
InChiKey
LHQIVPZNXOWFGU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Carbonolide B 的 C-9–C-16 片段的立体特异性合成,Carbomycin B 的苷元
    摘要:
    (R)-7-羟基-(2E,4E)-辛二烯酸甲酯 (9) 及其 (2E,4Z)-异构体 (16) 的立体特异性合成路线,前者可以是 16 元的有用化学前体讨论了卡霉素 B (carbonolide B) 的 -环苷元。化合物 9 对应于其 C-9-C-16 片段,是从甲基 2-脱氧-α-D-阿拉伯酮-吡喃己糖苷 (2) 开始合成的。脱氧糖 2 通过 4,6-二氯-2,4,6-三脱氧-α-D-lyxo-hexopyranoside 衍生物转化为掩蔽的 2,4,6-trideoxy-D-threo-hexopyranose (6)。6 用对甲苯磺酰氯和三乙胺处理得到 3-O-乙酰基-1,5-脱水-2,4,6-三脱氧-D-threo-hex-1-enitol,它与乙酸汞(II)反应转化为 (R)-5-羟基-(2E)-己烯醛 (8)。8 与 Wittig 试剂反应得到 (2E,4E)-异构体 9。
    DOI:
    10.1246/bcsj.51.3035
点击查看最新优质反应信息

文献信息

  • Novel non-natural C-linked carbo-beta-peptides with robust secondary structures
    申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    公开号:US20040192885A1
    公开(公告)日:2004-09-30
    This invention relates to Novel nonnatural C-linked carbo-&bgr;-peptides with robust secondary structures, which comprises the synthesis of a new class of &bgr;-peptides called C-linked carbo-&bgr;-peptides, most of which are favorably disposed for the formation of stable helical structures. 1 n=0, 1, 2, 3 . . . R=H, Boc, Cbz, Fmoc, acetyl or salts such as HCl, TFA and others R 1 =—O alkyl, —O-aralkyl, -amine, alkylamine, aryalkyl maine R 2 =R 3 =R 4 =R 5 =H R 2 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 3 =R 4 =R 5 =H R 3 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 4 =R 5 =H R 4 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 3 =R 5 =H R 5 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 3 =R 4 =H R 2 =R 4 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 3 =R 5 =H R 3 =R 5 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 4 =H R 2 =R 5 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 3 =R 4 =H R 3 =R 4 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 5 =H R 2 =R 3 =sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 4 =R 5 =H R 4 =R 5 sugar or hydroxy alkyl, amino alkyl/thioalkyl, R 2 =R 3 =H Sugars can be monosaccharide pentoses such as D-xylo, D-ribo, D-lyxo, D-ara or the L-sugars such as L-xyl, L-rib, L-lyxo, L-ara in furanoside or pyranoside form; hexoses such as D and L-glc, D and L-gal, D and L-man, D and L-gul, D and L-all, etc. in furanoside/pyranoside form; disaccharides such as lactose, maltose, cellobiose etc.; filly protected as acetates, benzoates, allyl or aralkyl ethers, alkylidene dioxolane derivatives, thio derivatives or totally unprotected sugars, D and L sugars in furanoside/pyranoside form having heterocyclic bases such as adenine, guanine, thymidine, cytosine or unnatural bases or heterocyclics having one or more than one heteroatoms such as O/N/S both in 5 and 6 membered rings, deoxy sugars/amino sugars natural/non-natural, rare sugars and higher sugars, bifunctional sugar amino acids.
    本发明涉及具有稳固二级结构的新型非天然C-连接碳水化合物-&bgr;-肽,包括合成一类称为C-连接碳水化合物-&bgr;-肽的新&bgr;-肽,其中大多数有利于形成稳定的螺旋结构。 1 n=0, 1, 2, 3 . R=H、Boc、Cbz、Fmoc、乙酰基或盐如 HCl、TFA 及其他 R 1 &等价物;-O 烷基、-O-芳烷基、-胺、烷基胺、芳烷基主碱 R 2 等价于;R 3 等价;R 4 等于;R 5 等价于;H R 2 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 3 等价于;R 4 等价于;R 5 等价于;H R 3 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价于;R 4 等价于;R 5 等价于;H R 4 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价于;R 3 等价于;R 5 等价于;H R 5 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价于;R 3 等价于;R 4 等价于;H R 2 等价于;R 4 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 3 等价于;R 5 等价于;H R 3 等价于;R 5 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价于;R 4 等价于;H R 2 等价于;R 5 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 3 等价于;R 4 等价于;H R 3 等价于;R 4 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价于;R 5 等价于;H R 2 等价于;R 3 等价于;糖或羟基烷基、氨基烷基/硫代烷基、R 4 等价于;R 5 等价于;H R 4 等价于;R 5 糖或羟基烷基、氨基烷基/硫代烷基、R 2 等价;R 3 等同于;H 糖可以是呋喃糖苷或吡喃糖苷形式的单糖五糖,如 D-xylo、D-ribo、D-lyxo、D-ara 或 L-糖,如 L-xyl、L-rib、L-lyxo、L-ara;也可以是呋喃糖苷或吡喃糖苷形式的六糖,如 D 和 L-glc、D 和 L-gal、D 和 L-man、D 和 L-gul、D 和 L-all 等。以呋喃糖苷/吡喃糖苷形式存在的六糖,如乳糖、麦芽糖、纤维二糖等。;作为醋酸盐、苯甲酸盐、烯丙基醚或芳烷基醚、亚烷基二氧戊环衍生物、硫代衍生物或完全未 受保护的糖、呋喃糖苷/吡喃糖苷形式的 D 和 L-糖,具有杂环碱基,如腺嘌呤、鸟嘌呤、胸腺嘧啶、胞嘧啶等、具有杂环基(如腺嘌呤、胸腺嘧啶、胞嘧啶)的呋喃糖苷/吡喃糖苷形式的 D 和 L 糖,或具有一个或一个以上杂原子(如 5 个和 6 个成员环中的 O/N/S)的非天然碱基或杂环,天然/非天然脱氧糖/氨基糖,稀有糖和高级糖,双功能糖氨基酸。
  • Leonard, John; Mohialdin, Soad; Swain, Philip, Synthetic Communications, 1989, vol. 19, # 20, p. 3529 - 3534
    作者:Leonard, John、Mohialdin, Soad、Swain, Philip
    DOI:——
    日期:——
  • NONNATURAL C-LINKED CARBO-BETA-PEPTIDES WITH ROBUST SECONDARY STRUCTURES
    申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    公开号:EP1701975A1
    公开(公告)日:2006-09-20
  • US7001982B2
    申请人:——
    公开号:US7001982B2
    公开(公告)日:2006-02-21
  • [EN] NONNATURAL C-LINKED CARBO-beta-PEPTIDES WITH ROBUST SECONDARY STRUCTURES<br/>[FR] CARBO- DOLLAR G(B)-PEPTIDES A LIAISON C NON NATURELS A STRUCTURES SECONDAIRES ROBUSTES
    申请人:COUNCIL SCIENT IND RES
    公开号:WO2005063797A1
    公开(公告)日:2005-07-14
    The present invention provides novel nonnatural C-linked carbo-β-peptides with robust secondary structures, which comprises the synthesis of a new class of β-peptides called C-linked carbo-β-peptides, most of which are favorably disposed for the formation of stable helical structures. Formula (I): wherein n= 0, 1, 2, 3 . . .; R= H, Boc, Cbz, Fmoc, acetyl or salts such as HC1, TFA and others; R1 = -O alkyl, -O-aralkyl, -amine, alkylamine, aryalkyl maine; R2 = R3 = R4 = R5 = H; R2 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R3 = R4 = R5 = H; R3 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R2 = R4 = R5 = H; R4 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R2 = R3 = R5 = H; R5 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R2 = R3 = R4 = H; R2 = R4 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R3 = R5 = H; R3 = R5 = sugar or hydroxyl alkyl, amino alkyl/thioalkyl, R2 = R4 = H; R2 = R5 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R3 = R4 = H; R3 = R4 = sugar or hydroxyl alkyl, amino alkyl/thioalkyl, R2 = R5 = H; R2 = R3 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R4 = R5 = H; R4 = R5 = sugar or hydroxy alkyl, amino alkyl/thioalkyl, R2 = R3 = H.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐